Trial reportBMC gastroenterology2025
Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial.
Trial report in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Walking for Health: Franz Tappeiner (1816-1902), Meran, and the Origins of Public Health-Oriented Physical Activity.International journal of environmental research and public health · 2026Article
- Digital health technologies for monitoring and managing IBD-related fatigue: A scoping review.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity in patients with inflammatory bowel disease (IBD) not only exacerbates symptoms but also interferes with treatment and leads to additional complications. Therefore, managing weight loss and preventing obesity are crucial. This study was designed to develop and implement a 10-week walking exercise program, facilitated by a mobile application, to evaluate its effectiveness in managing weight in obese IBD patients.
methodsThis study was designed as a single-blind parallel-group randomized clinical trial. We enrolled 54 participants, randomly allocating 27 to the intervention group and 27 to the control group. The intervention group received educational materials, such as videos, and participants were instructed to walk a minimum of 7,000 steps on at least five days each week for a duration of 10 weeks. Additionally, they were required to submit weekly updates on weight-related information to the researchers. The primary outcomes measured were body mass index (BMI), body fat percentage, and skeletal muscle mass. Secondary outcomes included perceived stress, fatigue, and quality of life.
resultsA total of 49 participants were included in the data collection (intervention group: n = 24, control group: n = 25). Post-intervention, the intervention group demonstrated significant reductions in BMI (t = 3.57, p =.001) and body fat percentage (Z = 3.11, p =.002) compared to the control group. Furthermore, perceived stress (t = 2.20, p =.038) and fatigue (t = 2.10, p =.047) significantly decreased in the intervention group, but no significant differences were observed when compared to the control group.
conclusionsThe 10-week walking program utilizing a mobile app effectively reduced body fat among participants, indicating its potential to improve health management in clinical settings. Further research is necessary to explore changes in muscle mass and psychological variables.
trial registrationKorea Clinical Trials Registry number KCT0009461, 24/05/2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.